Safety of Lenalidomide (Len) 10Mg in Non-Del(5Q) Versus Del(5Q) in the Treatment of Patients (Pts) with Lower-Risk Myelodysplastic Syndromes (Mds): Pooled Analysis of Treatment-Emergent Adverse Events (Teaes)

AuthID
 P-00K-6FZ
14
Author(s)
Santini, V
·
Croepper, S
·
Giagounidis, A
·
Hellstrom Lindberg, E
·
Mufti, GJ
·
Sanz, G
·
Skikne, B
·
Hoenekopp, A
·
Seguy, F
·
Zhong, JH
·
Fenaux, P
Document Type
Abstract
Year published
2015
Published
in BLOOD, ISSN: 0006-4971
Volume: 126, Issue: 23
Conference
57Th Annual Meeting of the American-Society-Of-Hematology, Date: DEC 05-08, 2015, Location: Orlando, FL, Sponsors: Amer Soc Hematol
Indexing
Wos®
Publication Identifiers
Wos: WOS:000368020103075
Source Identifiers
ISSN: 0006-4971
Export Publication Metadata
Marked List
 Add to Marked List
Info
At this moment we don't have any links to full text documens.

A place for researchers and their institutions

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service